What is she best known for?
The fields of study she is best known for:
- Bacteria
- Antibiotics
- Gene
The scientist’s investigation covers issues in Microbiology, Antibacterial agent, Tigecycline, Efflux and Glycylcycline.
Her Microbiology research incorporates themes from Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacteriaceae.
The Antibacterial agent study combines topics in areas such as Multiple drug resistance, β lactamases, Antimicrobial, Staphylococcus aureus and Sulbactam.
Patricia A. Bradford has included themes like Mutant, Acinetobacter baumannii, Acinetobacter, Molecular biology and Antibiotic resistance in her Efflux study.
The concepts of her Glycylcycline study are interwoven with issues in Ribosomal RNA and A-site.
Her Drug resistance study combines topics from a wide range of disciplines, such as Vaborbactam, Avibactam, Bacteria and Enzyme.
Her most cited work include:
- Ceftriaxone-resistant salmonella infection acquired by a child from cattle. (462 citations)
- Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. (432 citations)
- Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases in New York City (418 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Microbiology, Antibacterial agent, Tigecycline, Antibiotics and Klebsiella pneumoniae.
Her Microbiology study integrates concerns from other disciplines, such as Pseudomonas aeruginosa, Enterobacteriaceae, Escherichia coli and Staphylococcus aureus.
Her Antibacterial agent study incorporates themes from Antimicrobial, Mutant, Vancomycin, Glycopeptide and Sulbactam.
The study incorporates disciplines such as Minocycline, Efflux, Colistin and Etest in addition to Tigecycline.
As part of one scientific family, she deals mainly with the area of Antibiotics, narrowing it down to issues related to the Piperacillin, and often Pharmacology.
Her Klebsiella pneumoniae research includes elements of Ciprofloxacin, Imipenem, Enterobacter, Ceftazidime and Drug resistance.
She most often published in these fields:
- Microbiology (72.22%)
- Antibacterial agent (37.96%)
- Tigecycline (26.85%)
What were the highlights of her more recent work (between 2016-2020)?
- Microbiology (72.22%)
- Klebsiella pneumoniae (22.22%)
- Broth microdilution (12.96%)
In recent papers she was focusing on the following fields of study:
Patricia A. Bradford mainly focuses on Microbiology, Klebsiella pneumoniae, Broth microdilution, Ceftazidime/avibactam and Pseudomonas aeruginosa.
Patricia A. Bradford combines subjects such as Enterococcus faecalis, Enterobacteriaceae and Acinetobacter baumannii with her study of Microbiology.
The Klebsiella pneumoniae study which covers Plasmid that intersects with Genome.
Her Broth microdilution study also includes
- Aztreonam, Streptococcus anginosus and Bacteroides fragilis most often made with reference to Avibactam,
- Colistin which intersects with area such as Tigecycline.
Her research in Pseudomonas aeruginosa intersects with topics in Vancomycin, Linezolid and Ventilator-associated pneumonia.
Her Antibiotics research integrates issues from Streptococcus, Bacteria, Staphylococcus and Drug resistance.
Between 2016 and 2020, her most popular works were:
- Interplay between β-lactamases and new β-lactamase inhibitors. (103 citations)
- Epidemiology of β-Lactamase-Producing Pathogens. (59 citations)
- In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015. (59 citations)
In her most recent research, the most cited papers focused on:
- Bacteria
- Antibiotics
- Gene
Patricia A. Bradford focuses on Microbiology, Klebsiella pneumoniae, Enterobacteriaceae, Avibactam and Clade.
Her Microbiology research incorporates elements of Research center and Health innovation.
Her studies in Klebsiella pneumoniae integrate themes in fields like Healthcare associated infections and Epidemiology.
Her research integrates issues of Broth microdilution, Antibiotic resistance and Aztreonam in her study of Enterobacteriaceae.
The various areas that Patricia A. Bradford examines in her Aztreonam study include Monobactam, Tigecycline, Colistin and Beta-Lactamase Inhibitors.
Her Beta-lactamase research includes themes of Antibiotics and Bacteria.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
